| Name | Vepsitamab |
|---|
| Description | Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |